Loading clinical trials...
Loading clinical trials...
Comparison of Prostate Cancer Detection Rates Obtained With Multiparametric MRI Targeted Transrectal Ultrasound Biopsies and Systematic Transrectal Ultrasound Biopsies.
The purpose of the study is to show that 3 targeted biopsies on the suspicious image detected by IRM, guided by a fusion of MRI and ultrasound- images with the Koelis ® system, will get no lower rate of cancer detection than those obtained by 12 systematic transrectal ultrasound-guided biopsies of the prostate.
The act of current practice evaluated by this research is the act of prostate biopsies : the patient will have to undergo 12 systematized transrectal echography guided biopsies of the prostate and 3 additional biopsies targeted on the suspicious lesion detected with MRI, which are both done in current practice. * A first operator is not informed of the location of the target. He will perform a series of 12 systematic transrectal ultrasound-guided biopsies of the prostate. * Immediately after the second operator will perform 3 additional targeted biopsies on the suspicious image detected by IRM, guided by a fusion of MRI and ultrasound- images with the Koelis ® system Act added by the research: Using a fusion of MRI - ultrasound images software system (Koelis ®).
Age
45 - 75 years
Sex
MALE
Healthy Volunteers
No
CHU Grenoble
Grenoble, France
Chu Edouard Herriot
Lyon, France
CHU Pitié salpêtrière
Paris, France
CHU Cochin
Paris, France
CHU Toulouse Rangueil
Toulouse, France
Clinique Pasteur
Toulouse, France
Start Date
June 1, 2014
Primary Completion Date
January 1, 2015
Completion Date
February 1, 2015
Last Updated
November 20, 2025
108
ACTUAL participants
systematic biopsies
PROCEDURE
Targeted biopsies guided by a fusion of MRI and ultrasound- images
PROCEDURE
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
NCT04550494
NCT05691465
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions